A

Assertio Holdings Inc
NASDAQ:ASRT

Watchlist Manager
Assertio Holdings Inc
NASDAQ:ASRT
Watchlist
Price: 0.9999 USD 2.13%
Market Cap: 95.3m USD
Have any thoughts about
Assertio Holdings Inc?
Write Note

Assertio Holdings Inc
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Assertio Holdings Inc
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
A
Assertio Holdings Inc
NASDAQ:ASRT
Cash Interest Paid
$2.6m
CAGR 3-Years
-38%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Cash Interest Paid
$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Cash Interest Paid
$2.9B
CAGR 3-Years
24%
CAGR 5-Years
13%
CAGR 10-Years
7%
Merck & Co Inc
NYSE:MRK
Cash Interest Paid
$1.2B
CAGR 3-Years
16%
CAGR 5-Years
7%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Assertio Holdings Inc
Glance View

Market Cap
95.4m USD
Industry
Pharmaceuticals

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 19 full-time employees. The firm's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The firm has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.

ASRT Intrinsic Value
1.5618 USD
Undervaluation 36%
Intrinsic Value
Price
A

See Also

What is Assertio Holdings Inc's Cash Interest Paid?
Cash Interest Paid
2.6m USD

Based on the financial report for Sep 30, 2024, Assertio Holdings Inc's Cash Interest Paid amounts to 2.6m USD.

What is Assertio Holdings Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
-43%

Over the last year, the Cash Interest Paid growth was -31%. The average annual Cash Interest Paid growth rates for Assertio Holdings Inc have been -38% over the past three years , -43% over the past five years .

Back to Top